Clinical Trials Directory

Trials / Completed

CompletedNCT00395902

Post Transplant Study

A Retrospective Evaluation of Sensipar Use in Renal Transplant Recipients

Status
Completed
Phase
Study type
Observational
Enrollment
50 (planned)
Sponsor
Amgen · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

Retrospective chart review to gather information on Sensipar patterns of use and effects on biochemical parameters in renal transplant recipients

Conditions

Interventions

TypeNameDescription
DRUGSensipar after Post Transplant

Timeline

Start date
2005-08-01
First posted
2006-11-06
Last updated
2007-12-28

Source: ClinicalTrials.gov record NCT00395902. Inclusion in this directory is not an endorsement.